Stick To The Plan – But Be Ready To Change
An Interview With ‘Rising Leader’ Christophe Bancel, CEO Of TISSIUM
Know your strengths, surround yourself with experts and ensure your solution “does what it says on the tin.” These are among the guiding principles of Christophe Bancel, co-founder of France’s biopolymer innovator TISSIUM, a health care start-up on the cusp of commercialization.
You may also be interested in...
Post-Brexit planning is now fully back on the agenda in the UK, and work to shape its post-EU medtech regulatory future is also restarting.
With the World Health Organization pressing for an inquiry into the coronavirus pandemic, it is clear that lessons must be learned for how future global public health emergencies must be handled. Medical technology has played a key role in halting the speed of the pandemic, but why has it taken an episode like COVID-19 for medtech’s true value to be recognized? ZS principal Brian Chapman says things must never go back to where they were.
Surveillance and track-and-trace have emerged as the new focus of the UK’s COVID-19 control strategy, but a workable plan is yet to crystalize.